Fig. 5.
Expression of IκB at mRNA (A) and protein (B) levels in primary leukemic cells from ATL patients and normal healthy subjects. (A) Total RNA was extracted from PBMC and assessed for IκB, IL-2R, or GAPDH mRNA expression. A representative Northern blot is shown from patients with ATL and healthy subjects (normal). (B) PBMC obtained from patients with ATL or healthy subjects (normal) were assessed for IκB by Western blot analysis.